Insiders Acarix AB Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 08:05:08 26/06/2024 BST			5-day change	1st Jan Change
0.0236 ^EUR	-16.90%		-21.33%	+55.26%

06-11	Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study	CI
05-27	Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	CI

Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	05-27	CI
Acarix AB Approves Board Elections	05-14	CI
Acarix Appoints New Members to the Advisory Board	02-15	CI
Acarix Names New CEO	02-01	MT
Acarix AB Announces CEO Changes	02-01	CI
Acarix CEO to Take Medical Leave; Acting CEO Appointed	03/10/23	MT
Acarix AB Announces CEO Changes	02/10/23	CI
Acarix AB Appoints Christian Lindholm as Executive Vice President	02/10/23	CI
Acarix AB Appoints Dr. Deepak R. Talreja Md as New Medical Advisor	28/08/23	CI
Acarix AB Elects Mikael Thorén as Director	11/05/23	CI
Acarix CEO Joins Pharmacolog in Same Role	09/01/23	MT
Acarix AB Appoints Helen Ljungdahl Round as New CEO	10/01/22	CI
Acarix Appoints Helen Ljungdahl Round as President Acarix Inc	28/09/21	CI
Acarix Recruits Helen Ljungdahl Round as Head of the Company’s Newly Established Us Subsidiary Acarix Inc	14/09/21	CI
Acarix AB Announces Board Changes	12/04/21	CI
Acarix AB Announces Executive Changes	14/05/20	CI
Acarix AB Announces Board Changes	20/05/19	CI
Acarix AB Appoints Per Perrson as Chief Executive Officer	13/11/18	CI
Acarix AB Recruits Per Persson as Chief Commercial Officer	23/05/18	CI
Acarix AB Appoints Christian Lindholm as its Interim Chief Executive Officer	23/02/18	CI

No results for this search